晚发型中重度急性呼吸窘迫综合征与更短生存时间和更高死亡率相关:一项两阶段关联研究
该研究纳入876例中重度ARDS患者,随机分为推导集(N=520)和验证集(N=356),分析ARDS发病后28天和60天生存时间。基于死亡率风险效应确定早发型与晚发型ARDS的数据驱动截断点为ICU入住48小时后。晚发型ARDS(N=273,31%)与更短28天生存时间相关(合并数据集HR=2.00,95%CI 1.47-2.72),也与更短60天生存时间相关(合并数据集HR=1.59,95%CI 1.20-2.10),并与更高28天死亡率(OR=1.46,95%CI 1.04-2.06)和60天死亡率(OR=1.44,95%CI 1.03-2.02)相关。结论认为晚发型中重度ARDS患者28天和60天观察期内生存时间更短、死亡率更高。
要点
- 晚发型ARDS定义为ICU入住48小时后发病,占中重度ARDS患者的31%(N=273)。
- 晚发型ARDS与更短28天生存时间相关:合并数据集HR=2.00,95%CI 1.47-2.72,P=1.10×10⁻⁵。
- 晚发型ARDS与更短60天生存时间相关:合并数据集HR=1.59,95%CI 1.20-2.10,P=1.22×10⁻³。
- 晚发型ARDS与更高28天死亡率相关:OR=1.46,95%CI 1.04-2.06,P=0.0305。
- 晚发型ARDS与更高60天死亡率相关:OR=1.44,95%CI 1.03-2.02,P=0.0313。
适用人群与场景
- 中重度ARDS患者(N=876),随机分为推导集(N=520)和验证集(N=356)。
诊断标准与关键阈值
- 晚发型ARDS定义为ICU入住48小时后发病。
研究设计与关键结果
- 研究类型为两阶段关联研究,纳入中重度ARDS患者876例,随机分为推导集520例和验证集356例。
- 晚发型ARDS(ICU入住48小时后发病)N=273,占31%。
- 28天生存时间:推导集HR=2.24(95%CI 1.48-3.39,P=1.24×10⁻⁴);验证集HR=2.16(95%CI 1.33-3.51,P=1.95×10⁻³);合并数据集HR=2.00(95%CI 1.47-2.72,P=1.10×10⁻⁵)。
- 60天生存时间:推导集HR=1.70(95%CI 1.16-2.48,P=6.62×10⁻³);验证集HR=1.78(95%CI 1.15-2.75,P=9.80×10⁻³);合并数据集HR=1.59(95%CI 1.20-2.10,P=1.22×10⁻³)。
- 28天死亡率:OR=1.46(95%CI 1.04-2.06,P=0.0305)。
- 60天死亡率:OR=1.44(95%CI 1.03-2.02,P=0.0313)。
证据类型、等级与局限
- 证据类型:两阶段关联研究(推导集与验证集)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为晚发型中重度ARDS患者28天和60天观察期内生存时间更短、死亡率更高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the association between acute respiratory distress syndrome (ARDS) onset time and prognosis.
METHODS: Patients with moderate to severe ARDS (N = 876) were randomly assigned into derivation (N = 520) and validation (N = 356) datasets. Both 28-day and 60-day survival times after ARDS onset were analyzed. A data-driven cutoff point between early- and late-onset ARDS was determined on the basis of mortality risk effects of onset times. We estimated the hazard ratio (HR) and odds ratio (OR) of late-onset ARDS using a multivariate Cox proportional hazards model of survival time and a multivariate logistic regression model of mortality rate, respectively.
RESULTS: Late-onset ARDS, defined as onset over 48 h after intensive care unit (ICU) admission (N = 273, 31%), was associated with shorter 28-day survival time: HR = 2.24, 95% CI 1.48-3.39, P = 1.24 × 10-4 (derivation); HR = 2.16, 95% CI 1.33-3.51, P = 1.95 × 10-3 (validation); and HR = 2.00, 95% CI 1.47-2.72, P = 1.10 × 10-5 (combined dataset). Late-onset ARDS was also associated with shorter 60-day survival time: HR = 1.70, 95% CI 1.16-2.48, P = 6.62 × 10-3 (derivation); HR = 1.78, 95% CI 1.15-2.75, P = 9.80 × 10-3 (validation); and HR = 1.59, 95% CI 1.20-2.10, P = 1.22 × 10-3 (combined dataset). Meanwhile, late-onset ARDS was associated with higher 28-day mortality rate (OR = 1.46, 95% CI 1.04-2.06, P = 0.0305) and 60-day mortality rate (OR = 1.44, 95% CI 1.03-2.02, P = 0.0313).
CONCLUSIONS: Late-onset moderate to severe ARDS patients had both shorter survival time and higher mortality rate in 28-day and 60-day observations.
参考来源
- Zhang R, Wang Z, Tejera P, et al. Late-onset moderate to severe acute respiratory distress syndrome is associated with shorter survival and higher mortality: a two-stage association study. Intensive Care Med. 2016. PMID: 28032130. doi:10.1007/s00134-016-4638-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。